ELUTIA INC. - CLASS A

Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics

04 апр 2022 07:00:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference

31 мар 2022 17:50:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results

03 мар 2022 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference

23 фев 2022 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022

17 фев 2022 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference

27 дек 2021 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces Closing of $14.0 Million Private Placement

08 дек 2021 16:31:29 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces $14.0 Million Private Placement

06 дек 2021 05:59:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences

15 ноя 2021 15:05:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics Reports Third Quarter 2021 Financial Results

09 ноя 2021 15:01:01 Источник Nasdaq GlobeNewswire

Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for Third Quarter 2021 Financial Results

25 окт 2021 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference

15 сен 2021 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

31 авг 2021 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Reports Second Quarter 2021 Financial Results

09 авг 2021 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

26 июл 2021 15:01:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix

07 июн 2021 07:00:02 Источник Nasdaq GlobeNewswire

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

28 апр 2021 15:05:01 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

26 апр 2021 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

20 апр 2021 15:05:00 Источник Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

01 мар 2021 15:05:00 Источник Nasdaq GlobeNewswire